ASHLEY BADAL: Open Payments
NPI 1093596850 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 27 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $346 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $274 |
| Axsome Therapeutics, Inc. | 7 | $207 |
| Alkermes, Inc. | 6 | $135 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| Indivior Inc. | 1 | $18 |
Products named: VRAYLAR, Auvelity, ARISTADA, VIVITROL, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
